Skip to main content
Main analysis: Mor Investments in the First Quarter: Profit Jumped, but Cash Return Still Depends on Subsidiaries
ByMay 27, 2026~5 min read

Mor Credit: Half the Framework Is Already Used, Profit Is Still Missing

Mor Credit has already received about NIS 25.6 million out of a loan framework of up to NIS 50 million from Mor Investments, while the equity-method line still shows no positive contribution. This is not a liquidity crisis, but it places the diversification move in a clearer position: parent capital first, profit proof later.

The follow-up question around Mor Credit is no longer a broad strategic question about entering non-bank credit. It is a narrower test of who funds the interim period. Mor Investments provided Mor Credit with about NIS 25.6 million in February and March 2026, out of a framework of up to NIS 50 million signed in January. In other words, roughly half of the framework was already used within two months, while the equity-method investment line still shows a small loss rather than a profit contribution. That does not make Mor Credit a liquidity problem: the framework is time-limited, each loan requires the company's approval, and the parent still has financial assets and dividends from investees. But the current judgment should be clear: Mor Credit still looks like a use of parent-company capital before it looks like a diversification engine returning value. The next proof point is not another statement about business expansion, but evidence of external funding, repayment by January 2027, or a clearer contribution to profit.

Half the framework has already been used

The new point is not the existence of the framework. That was already part of the risk after the acquisition. What changed in the first quarter is the speed of use: on January 22, 2026, the company signed the loan-framework agreement, and by February and March it had already provided roughly half of it. For a financial company trying to add a lending activity, owner funding during a build-out phase is not unusual by itself. What is abnormal here is how quickly the move shifted from a diversification option to a stage where real parent-company money is already funding a portfolio that has not yet shown profit contribution.

CheckpointWhat appeared in the first quarter
Loan framework for Mor CreditUp to NIS 50 million, valid until January 22, 2027
Actual use in February and MarchAbout NIS 25.6 million
Consolidated balance-sheet loan25.746 million shekels to an equity-method company
Investing cash flow25.570 million shekels loan to an equity-method company
Equity-method contribution0.223 million shekels loss
Additional transaction-related liability4.792 million shekels guarantee liability for an equity-method company

This table does not prove that the activity itself lost money. The disclosure does not break out its full contribution separately from the other equity-method investments. It does prove something more important for this continuation: in a quarter when the parent had already provided the amount above, that investment layer still did not give investors a positive profit signal to offset the capital use.

The money is accessible, but it comes from the parent layer

The right way to read the pressure is to separate funding ability from capital-allocation quality. On a consolidated basis, the group ended the quarter with NIS 125.8 million in cash and cash equivalents and NIS 68.7 million in operating cash flow. That sounds comfortable, but the activity should not be read only through the consolidated lens. It was acquired to broaden the profit base beyond capital-market exposure, and the loans to it are a parent-company capital-allocation decision.

The separate parent-company data is more precise. Operating cash flow at the parent was negative NIS 6.0 million, investing cash flow was positive NIS 9.0 million, and financing cash flow was negative NIS 0.8 million. All-in cash flexibility after actual cash uses looked reasonable for one quarter, because the parent received NIS 22.4 million in dividends from investees and net realized financial assets in a way that supported investing cash flow, despite providing NIS 26.4 million of loans to investees. At the end of March, the parent held NIS 16.2 million in cash and NIS 219.8 million of financial assets measured at fair value.

That is the nuance: the company can fund the first stage. The issue is not immediate cash scarcity, but the analytical cost of using that cash. Every shekel provided to Mor Credit is a shekel that is not available in the same way for distributions, buybacks, debt reduction, or flexibility against market volatility. In an asset-management model, where the core engines are expected to generate management fees and upstream dividends, a new lending activity needs to prove fairly quickly that it is not merely consuming accessible capital, but can also return that capital at an adequate yield.

The framework is limited, so the proof point is close

There is also a reassuring side: the agreement does not automatically require the company to provide the full NIS 50 million. Each loan requires prior written approval and remains at the company's sole discretion. The loans are due by January 22, 2027, and are unlinked while carrying quarterly accrued interest at the rate set in the agreement. Those terms keep the move from looking like an unlimited open-ended commitment.

That is exactly why 2026 becomes a focused proof year. If the activity shows external funding that replaces parent loans, repayment of the framework, or a clearer profit contribution, the framework will look like reasonable interim funding for a new activity. If the next quarters show further use without disclosure on credit quality, yield, delinquencies, or external funding sources, the diversification move will remain mainly a capital consumer inside a company already being tested for parent-level cash access. The current conclusion is that Mor Credit still does not improve the company's earnings quality, but it already changes how its capital flexibility should be tested.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction